First described in 2020, multi-system inflammatory syndrome in children (MIS-C) is an,
initially life-threatening, disease characterised by severe inflammation and following …

Introduction Reports of multisystem inflammatory syndrome in children (MIS-C), following
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, have been …

Multisystem inflammatory syndrome in children : Current Opinion in Pediatrics Multisystem
inflammatory syndrome in children : Current Opinion in Pediatrics Log in or Register Subscribe …

Multisystem inflammatory syndrome in children (MIS-C) is a new syndrome that was first
reported in Europe and the United States in 2020. Although the mechanism for onset of MIS …

The SARS-CoV2 pandemic is the most significant global health emergency of the last
century. While the pathophysiology of SARS-CoV2 is understood, the early and long-term …

Since the beginning of COVID-19 pandemic, a new post-infectious inflammatory
manifestation of SARS-CoV-2 affecting children has been described. It was defined as …

Background Multiinflammatory syndrome in children (MIS-C) is a novel and rare
inflammatory disorder associated with severe acute respiratory syndrome coronavirus 2 …

Multisystem inflammatory syndrome (MIS-C) is a rare condition associated with COVID-19
affecting children, characterized by severe and aberrant systemic inflammation leading to …

Initially, children were thought to be spared from disease caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2). However, a month into the epidemic, a novel …

Objective To assess demographic, clinical, and biomarker features distinguishing patients
with multisystem inflammatory syndrome in children (MIS-C); compare MIS-C sub …